OOIR: Observatory of International Research

Papers

(The TQCC of Nature Reviews Nephrology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
A UMOD variant with intermediate effects	586
Mentorship in the lives of scholars	363
Daratumumab for AL amyloidosis	340
Kidney health within the broader non-communicable disease agenda	314
Age-old musings: twenty-first century management of advanced kidney disease in older individuals	289
Making advance care planning easier for adults with kidney disease and their clinicians	282
Role of the gut microbiota in the pathogenesis of IgA nephropathy	281
The GLP-1 receptor agonist revolution comes to nephrology	255
Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions	255
Vaccination in patients with kidney failure: lessons from COVID-19	246
Designing acute kidney injury clinical trials	210
Treatment of chronic kidney disease in older populations	198
Uropathogen and host responses in pyelonephritis	195
Disaster preparedness for patients with kidney disease	169
Genetic determinants of urine and plasma metabolite levels	167
A single-cell atlas of DKD treatment responses	162
Daprodustat for anaemia in CKD	161
Non-invasive molecular imaging of kidney diseases	156
Consideration of sex differences is necessary to achieve health equity	153
Beyond state borders: transforming dialysis care for undocumented immigrants	146
Roles of sensory receptors in non-sensory organs: the kidney and beyond	144
GWAS scorecard prioritizes kidney genes using coding and regulatory variants	137
Complosome — the intracellular complement system	136
Transport and barrier mechanisms that regulate ciliary compartmentalization and ciliopathies	136
Phosphate sensing via PTC glycolysis	135

Menopause and chronic kidney disease	131
Mutational signatures of ccRCC vary between geographical regions	123
Bringing Pride to nephrology	120
Interferon blockade in lupus: effects on antiviral immunity	118
Informing clinical decision making during a pandemic — a call for better preparedness	117
Reducing preventable acute kidney injury in a hospital setting	117
Publisher Correction: Sustainable Development Goals relevant to kidney health: an update on progress	116
Reference-trial-informed design to explore treatment effects in trial-underrepresented subgroups	113
Clonal haematopoiesis and AKI	112
Aquaporin water channels: roles beyond renal water handling	111
The roles of hyaluronan in kidney development, physiology and disease	111
Benefits of actin cytoskeleton stabilization	111
Increasing diversity and inclusion in nephrology clinical trials	111
Innovating dialysis through computational modelling of hollow-fibre haemodialysers	110
International expert consensus statement on the diagnosis and management of congenital nephrogenic diabetes insipidus (arginine vasopressin resistance)	108
From mapping kidney function to mechanism and prediction	106
Immunometabolic consequences of IL-23	105
ERA-EDTA congress 2021	101
NUAK1 promotes kidney fibrosis	98
Identification of erythropoietin-producing cells	98
Design of a renal-sparing antifungal	95
Tertiary lymphoid organs contribute to kidney allograft rejection	94
Heat and health inequity: acting on determinants of health to promote heat justice	91
Treatment of SLE with anti-CD19 CAR-T cells	88
From fat to filter: the effect of adipose tissue-derived signals on kidney function	87
Pathological mechanisms of kidney disease in ageing	86
Neutrophils and NETs in kidney disease	85
RNA-binding proteins and their role in kidney disease	82
Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics	81
Salt substitution: opportunities and challenges for nephrology	79
The role of complement in kidney disease	77
Long-term health outcomes associated with hydration status	77
The evolving landscape of immune-mediated glomerular diseases	75
Reaping the rewards of mechanistic discovery in glomerular disease	74
Author Correction: Chronic cardiovascular–kidney disorder: a new conceptual framework	73
MSC therapy for diabetic kidney disease and nephrotic syndrome	72
A golden year of innovative kidney disease therapeutics	70
Reducing stress-induced CHOP is renoprotective	69
Network medicine: an approach to complex kidney disease phenotypes	66
A pathway of osmotic stress-induced necroptosis	62
An integrated approach towards a public health perspective on chronic kidney disease	60
Portable, wearable and implantable artificial kidney systems: needs, opportunities and challenges	58
Drosophila melanogaster: a simple genetic model of kidney structure, function and disease	56
Patient-centred approaches for the management of unpleasant symptoms in kidney disease	56
Combination therapy for kidney disease in people with diabetes mellitus	55
Self-reactive innate-like B-1 cells infiltrate grafts	54
Methionine metabolism: a driver of ADPKD	52
New insights into the ccRCC microenvironment	51
Consequences of famine and malnourishment on kidney health	49
CKD-specific ASCVD risk prediction tools	49

Consequence of microvascular inflammation in transplantation	49
Ketogenic diet benefits in critically ill patients with sepsis	49
The cilia mechanosensation debate gets (bio)physical	48
Transcatheter mitral valve repair in patients with CKD	47
Continuing kidney care in conflicts	46
Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney	46
Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function	46
Educating primary healthcare providers about kidney disease	46
GalNAc-T14-associated defects in B cell homing in IgA nephropathy	45
Kidney complications of parasitic diseases	45
Organ donation and transplantation: a multi-stakeholder call to action	45
Gene therapy in a model of nephrotic syndrome	43
Role of the cGAS–STING pathway in systemic and organ-specific diseases	43
Mechanism of B cell survival in lupus nephritis	42
Dietary protection of proximal tubules in diabetes	41
Stem cell–kidney transplantation in Schimke immuno-osseous dysplasia	40
Nephrology education and training in Africa	40
Targeting IL-1Ra to attenuate fungal infection	40
The kidney is a novel target of metformin	39
Multifaceted innovations needed to advance transplant nephrology	38
Born too soon: lifelong kidney risks and the importance of early intervention	37
Mannose as a driver of γδ T cell kidney infiltration	36
Steps forward in the treatment of IgA nephropathy	36
Metabolic alterations in hereditary and sporadic renal cell carcinoma	35
A guide to gene–disease relationships in nephrology	34
Cardiovascular mortality increases with stage of cardiovascular–kidney–metabolic syndrome	34
Epithelial cell states associated with kidney and allograft injury	33
Chronic cardiovascular–kidney disorder: a new conceptual framework	32
Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope	31
Role of necroptosis in kidney health and disease	30
A multidisciplinary approach to cardiorespiratory fitness in CKD	30
Fasting induces structural and functional changes in the peritoneal membrane	29
ALCAM–CD6 in lupus nephritis	28
Insights into the impact of pregnancy on kidney disease	28
Derivation of collecting duct organoids	28
Author Correction: Regulatory T cells in autoimmune kidney diseases and transplantation	26
Author Correction: Therapeutic advances in COVID-19	26
Strategies to achieve gender equity in nephrology	26
From big data to smart decisions: artificial intelligence in kidney risk assessment	25
Tissue-resident memory T cells in the urogenital tract	25
The impact of intrauterine growth restriction and prematurity on nephron endowment	25
Renal nerves in physiology, pathophysiology and interoception	25
Exercise and chronic kidney disease: potential mechanisms underlying the physiological benefits	24
Experimental evidence for a pathogenic role of anti-PLA2R1 antibodies in membranous nephropathy	24
Acute kidney injury in patients with burns	24
Switching off SOX9 for epithelial recovery after AKI	24
The perils of misinformation: when health literacy goes awry	24
Cryo-EM structure of AVP–V2 receptor complex	23
Functional consequences of spatial, temporal and ligand bias of G protein-coupled receptors	22
Hope for resistant hypertension through BrigHTN and PRECISION	22
Digital determinants of health: opportunities and risks amidst health inequities	21
CD38 — a new target in renal immune disease	21
Collagen formation, function and role in kidney disease	21
Impact of persistent conflict and destabilizing events on dialysis care	20
The impact of population ageing on the burden of chronic kidney disease	19
The genetics of kidney stone disease and nephrocalcinosis	19
Crosstalk between glomeruli and tubules	19
Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup	18
Nephrology and women’s health post-Roe v. Wade: we must do better	17
Chlorthalidone in advanced CKD	17
Improving the quality of pharmacoepidemiological studies using the target trial emulation framework	17